Apr 07, 2020 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM
Apr 15, 2020 - The following slide deck was published by Tomtom NV in conjunction with their 2020 Q1 earnings call.
Apr 14, 2020 - Bausch (BHC) begins a clinical study on Virazole in combination with standard-of-care therapy to treat adults with respiratory distress due to COVID-19 in Canada.
Apr 17, 2020 - SLB earnings call for the period ending March 31, 2020.
Apr 21, 2020 - Novartis (NVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Apr 20, 2020 - Novartis (NVS) announces FDA's approval to evaluate hydroxychloroquine in hospitalized patients with COVID-19 in a late-stage study. The company is evaluating several of its drugs to treat COVID-19.
Apr 22, 2020 - Targeted therapies for treating sickle cell disease are finally here after a 60-year wait.
Apr 21, 2020 - Investor focus is likely to be on the impact of the coronavirus outbreak on Lilly's (LLY) performance when it reports first-quarter results.
Apr 28, 2020 - Novartis AG (NYSE:NVS) Q1 2020 Earnings Conference Call April 28, 2020, 07:00 ET Company Participants Samir Shah - Global Head, IR Vasant Narasimhan - CEO Marie-France Tschudin - President, Novartis P
Apr 30, 2020 - The following slide deck was published by Telenet Group Holding NV in conjunction with their 2020 Q1 earnings call.